Skip to main content

Advertisement

SpringerLink
Log in

Management and outcome of salivary duct carcinoma in major salivary glands

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with poor prognosis. Its histomorphology is distinctly reminiscent of the ductal carcinoma of the breast. We reviewed the treatment and outcome of SDCs at a single tertiary care centre. Twenty-five cases of SDC of major salivary gland origin, diagnosed and treated at the Department of Otolaryngology, Head and Neck Surgery, Helsinki University Central Hospital, Helsinki, Finland, during a 14-year period from 1997 to 2011, were reviewed retrospectively. Survival outcome was analyzed for 18 patients with a minimum follow-up of 24 months. There were 16 male (64 %) and 9 female (36 %) patients with a median age of 61 years (range 36–82 years). The majority of the cases occurred in the parotid gland (n = 21, 84 %) followed by the submandibular gland (n = 4, 16 %). The primary treatment consisted of surgical resection in all cases and 17 (68 %) patients also underwent neck dissection. Most of the patients (n = 18, 72 %) were treated with postoperative radiotherapy. Seven patients (28 %) had a disease recurrence within a median follow-up time of 15 months (range 3–27 months). In the group (n = 18) with a minimum follow-up time of 24 months, the 2- and 5-year overall and disease-specific survival rates were 66, 41 % and 75, 55 %, respectively. These results confirm the aggressive nature of SDCs in major salivary glands. Diagnostics and management of these tumours need to be centralized in experienced surgical Head and Neck Oncology Centres, and new treatment strategies should be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Finnish Cancer Registry, Cancer Society of Finland 2011. http://www.cancer.fi/syoparekisteri/en/. Accessed June 15th, 2011

  2. Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Mäkitie A, Virtaniemi J, Hinkka S, Grénman R (2005) Salivary gland cancer in Finland 1991–96: an evaluation of 237 cases. Acta Otolaryngol 125:207–214

    Article  PubMed  Google Scholar 

  3. Kleinsasser O, Klein HJ, Hubner G (1968) Salivary duct carcinoma: a group of salivary gland tumors analogous to mammary duct carcinoma (German). Arch Klin Exp Ohren Nasen Kehlkopfheilkd 192:100–105

    Article  PubMed  CAS  Google Scholar 

  4. Etges A, Pinto DS Jr, Kowalski LP, Soares FA, Araujo VC (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol 56:914–918

    Article  PubMed  CAS  Google Scholar 

  5. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG et al (1994) Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 54:5675–5682

    PubMed  CAS  Google Scholar 

  6. Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103:2526–2533

    Article  PubMed  Google Scholar 

  7. Skálová A, Stárek KucerováV, Szépe P, Plank L (2001) Salivary duct carcinoma—a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression. Pathol Res Pract 197:621–626

    Article  PubMed  Google Scholar 

  8. Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK (2010) Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res 16:2266–2274

    Article  PubMed  CAS  Google Scholar 

  9. Prat A, Parera M, Reyes V, Peralta S, Cedrés S, Andreu J, Huguet P, del Campo JM (2008) Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck 30:680–683

    Article  PubMed  Google Scholar 

  10. Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS (2007) Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 29:907–912

    Article  PubMed  Google Scholar 

  11. Nashed M, Casasola RJ (2009) Biological therapy of salivary duct carcinoma. J Laryngol Otol 123:250–252

    Article  PubMed  CAS  Google Scholar 

  12. Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 77:223–230

    Article  PubMed  CAS  Google Scholar 

  13. Hosal AS, Fan C, Barnes L, Myers EN (2003) Salivary duct carcinoma. Otolaryngol Head Neck Surg 129:720–725

    Article  PubMed  Google Scholar 

  14. Guzzo M, Di Palma S, Grandi C, Molinari R (1997) Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 19:126–133

    Article  PubMed  CAS  Google Scholar 

  15. Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M (2001) Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer 93:344–350

    Article  PubMed  CAS  Google Scholar 

  16. Delgado R, Vuitch F, Albores-Saavedra J (1993) Salivary duct carcinoma. Cancer 72:1503–1512

    Article  PubMed  CAS  Google Scholar 

  17. Kapadia SB, Barnes L (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11:1033–1038

    PubMed  CAS  Google Scholar 

  18. Fan CY, Wang J, Barnes EL (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistological analysis of 13 cases and review of the literature. Am J Surg Pathol 24:579–586

    Article  PubMed  CAS  Google Scholar 

  19. Williams MD, Roberts DE, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK (2007) Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 31:1645–1652

    Article  PubMed  Google Scholar 

  20. Jaspers HC, Verbist BM, Schoffelen R, Mattijssen V, Slootweg PJ, van der Graaf WT, van Herpen CM (2011) Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J Clin Oncol 29:473–476

    Article  Google Scholar 

  21. Locati LD, Quattrone P, Bossi P, Marchianò AV, Cantù G, Licitra L (2003) A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Ann Oncol 14:1327–1328

    Article  PubMed  CAS  Google Scholar 

  22. Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG (1996) Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol 27:561–566

    Article  PubMed  CAS  Google Scholar 

  23. Roh JL, Cho KJ, Kwon GY, Choi SH, Nam SY, Kim SY (2008) Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma. J Surg Oncol 97:596–600

    Article  PubMed  CAS  Google Scholar 

  24. Feinstein TM, Lai SY, Lenzner D, Gooding W, Ferris RL, Grandis JR, Myers EN, Johnson JT, Heron DE, Argiris A (2011) Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head Neck 33:318–323

    PubMed  Google Scholar 

  25. Adelstein DJ, Rodriguez CP (2011) What is new in the management of salivary gland cancers? Curr Opin Oncol 23:249–253

    Article  PubMed  CAS  Google Scholar 

  26. Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P (2007) Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg 133:1031–1036

    Article  PubMed  Google Scholar 

  27. Milano A, Longo F, Basile M, Iaffaioli RV, Caponigro F (2007) Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 43:729–734

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors want to thank the Helsinki University Central Hospital Research Funds.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head and Neck Surgery, Helsinki University Central Hospital, University of Helsinki, P.O. Box 220, 00029 HUCH, Helsinki, Finland

    Elina Salovaara, Olli Hakala, Leif Bäck & Antti A. Mäkitie

  2. Department of Otolaryngology, Head and Neck Surgery, Oulu University Hospital, Oulu, Finland

    Petri Koivunen

  3. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

    Kauko Saarilahti

  4. Department of Pathology, São Leopoldo Mandic Institute and Research Center, Campinas, Brazil

    Fabricio Passador-Santos

  5. Department of Pathology, University of Helsinki, Helsinki, Finland

    Ilmo Leivo

  6. Department of Pathology, University of Turku, Turku, Finland

    Ilmo Leivo

Authors
  1. Elina Salovaara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olli Hakala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leif Bäck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Petri Koivunen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kauko Saarilahti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fabricio Passador-Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ilmo Leivo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Antti A. Mäkitie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antti A. Mäkitie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salovaara, E., Hakala, O., Bäck, L. et al. Management and outcome of salivary duct carcinoma in major salivary glands. Eur Arch Otorhinolaryngol 270, 281–285 (2013). https://doi.org/10.1007/s00405-012-1997-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-012-1997-4

Keywords

Search

Navigation